Literature DB >> 11173131

Low-dose hypersensitivity: current status and possible mechanisms.

M C Joiner1, B Marples, P Lambin, S C Short, I Turesson.   

Abstract

PURPOSE: To retain cell viability, mammalian cells can increase damage repair in response to excessive radiation-induced injury. The adaptive response to small radiation doses is an example of this induced resistance and has been studied for many years, particularly in human lymphocytes. This review focuses on another manifestation of actively increased resistance that is of potential interest for developing improved radiotherapy, specifically the phenomenon in which cells die from excessive sensitivity to small single doses of ionizing radiation but remain more resistant (per unit dose) to larger single doses. In this paper, we propose possible mechanisms to explain this phenomenon based on our data accumulated over the last decade and a review of the literature.
CONCLUSION: Typically, most cell lines exhibit hyper-radiosensitivity (HRS) to very low radiation doses (<10 cGy) that is not predicted by back-extrapolating the cell survival response from higher doses. As the dose is increased above about 30 cGy, there is increased radioresistance (IRR) until at doses beyond about 1 Gy, radioresistance is maximal, and the cell survival follows the usual downward-bending curve with increasing dose. The precise operational and activational mechanism of the process is still unclear, but we propose two hypotheses. The greater amount of injury produced by larger doses either (1) is above a putative damage-sensing threshold for triggering faster or more efficient DNA repair or (2) causes changes in DNA structure or organization that facilitates constitutive repair. In both scenarios, this enhanced repair ability is decreased again on a similar time scale to the rate of removal of DNA damage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11173131     DOI: 10.1016/s0360-3016(00)01471-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  121 in total

Review 1.  Hormesis, an update of the present position.

Authors:  Lennart Johansson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-26       Impact factor: 9.236

2.  In vitro evaluation of 213Bi-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage.

Authors:  Katia Vandenbulcke; Filip De Vos; Fritz Offner; Jan Philippé; Christos Apostolidis; Roger Molinet; Tuomo K Nikula; Klaus Bacher; Virginie de Gelder; Anne Vral; Christophe Lahorte; Hubert Thierens; Rudi A Dierckx; Guido Slegers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-03       Impact factor: 9.236

3.  DNA double-strand breaks as potential indicators for the biological effects of ionising radiation exposure from cardiac CT and conventional coronary angiography: a randomised, controlled study.

Authors:  Dominik Geisel; Elke Zimmermann; Matthias Rief; Johannes Greupner; Michael Laule; Fabian Knebel; Bernd Hamm; Marc Dewey
Journal:  Eur Radiol       Date:  2012-04-17       Impact factor: 5.315

4.  Radiobiological Response of Cervical Cancer Cell Line in Low Dose Region: Evidence of Low Dose Hypersensitivity (HRS) and Induced Radioresistance (IRR).

Authors:  Saikat Das; Rabiraja Singh; Daicy George; T S Vijaykumar; Subhashini John
Journal:  J Clin Diagn Res       Date:  2015-06-01

Review 5.  Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy.

Authors:  Anish Prasanna; Mansoor M Ahmed; Mohammed Mohiuddin; C Norman Coleman
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

6.  Cytogenetic effects of low-dose radiation with different LET in human peripheral blood lymphocytes.

Authors:  E A Nasonova; N L Shmakova; O V Komova; L A Mel'nikova; T A Fadeeva; E A Krasavin; S Ritter
Journal:  Radiat Environ Biophys       Date:  2006-10-10       Impact factor: 1.925

7.  Low dose hyper-radiosensitivity in human lung cancer cell line A549 and its possible mechanisms.

Authors:  Xiaofang Dai; Dan Tao; Hongge Wu; Jing Cheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

8.  Suppression of neoplastic transformation in vitro by low doses of low LET radiation.

Authors:  J Leslie Redpath
Journal:  Dose Response       Date:  2006-11-27       Impact factor: 2.658

9.  Non-problematic risks from low-dose radiation-induced DNA damage clusters.

Authors:  Daniel P Hayes
Journal:  Dose Response       Date:  2008-01-16       Impact factor: 2.658

Review 10.  Peptide-targeted radionuclide therapy for melanoma.

Authors:  Yubin Miao; Thomas P Quinn
Journal:  Crit Rev Oncol Hematol       Date:  2008-04-02       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.